Paeoniflorin loaded liposomes modified with glycyrrhetinic acid for liver-targeting: preparation, characterization, and pharmacokinetic study

References

• Böttger R, Pauli G, Chao P-H, Al Fayez N, Hohenwarter L, Li S-D. 2020. Lipid-based nanoparticle technologies for liver targeting. Adv Drug Deliv Rev. 154–155:79–101. doi: 10.1016/j.addr.2020.06.017.
   PubMed Web of Science ®Google Scholar
• Cao Y, Xiong J, Guan X, Yin S, Chen J, Yuan S, Liu H, Lin S, Zhou Y, Qiu J, et al. 2023. Paeoniflorin suppresses kidney inflammation by regulating macrophage polarization via klf4-mediated mitophagy. Phytomedicine. 116:154901. doi: 10.1016/j.phymed.2023.154901.
   PubMed Web of Science ®Google Scholar
• Chen J, Lin Y, Wu M, Li C, Zhang Y, Chen D, Cheng Y. 2021. Drug-free liposomes containing mannosylated ligand for liver-targeting: synthetic optimization, liposomal preparation, and bioactivity evaluation. J Biomed Nanotechnol. 17(12):2455–2465. doi: 10.1166/jbn.2021.3204.
   PubMed Web of Science ®Google Scholar
• Chen L, Wei S, Liu H, Li J, Jing M, Tong Y, Li R, Wen J, Zhan H, Zhao Y. 2021. Paeoniflorin protects against anit-induced cholestatic liver injury in rats via the activation of sirt1-fxr signaling pathway. Evid Complement Alternat Med. 2021:1–12. doi: 10.1155/2021/8479868.
   Web of Science ®Google Scholar
• Chen L, Zhao X, Wei S, Ma X, Liu H, Li J, Jing M, Wang M, Zhao Y. 2021. Mechanism of paeoniflorin on anit-induced cholestatic liver injury using integrated metabolomics and network pharmacology. Front Pharmacol. 12:737630. doi: 10.3389/fphar.2021.737630.
   PubMed Web of Science ®Google Scholar
• Choi KY, Saravanakumar G, Park JH, Park K. 2012. Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer. Colloids Surf B Biointerfaces. 99:82–94. doi: 10.1016/j.colsurfb.2011.10.029.
   PubMed Web of Science ®Google Scholar
• Cui Y, Mo Y, Zhang Q, Tian W, Xue Y, Bai J, Du S. 2018. Microneedle-assisted percutaneous delivery of paeoniflorin-loaded ethosomes. Molecules. 23(12):3371. doi: 10.3390/molecules23123371.
   PubMed Web of Science ®Google Scholar
• Deepak P, Kumar P, Arya DK, Pandey P, Kumar S, Parida BP, Narayan G, Singh S, Rajinikanth PS. 2023. C(RGDFK) anchored surface manipulated liposome for tumor-targeted tyrosine kinase inhibitor (TKI) delivery to potentiate liver anticancer activity. Int J Pharm. 642:123160. doi: 10.1016/j.ijpharm.2023.123160.
   PubMedGoogle Scholar
• Dymek M, Sikora E. 2022. Liposomes as biocompatible and smart delivery systems – the current state. Adv Colloid Interface Sci. 309:102757. doi: 10.1016/j.cis.2022.102757.
   PubMed Web of Science ®Google Scholar
• E Silva ATM, Maia ALC, de Oliveira Silva J, de Barros ALB, Soares DCF, de Magalhães MTQ, José Alves R, Ramaldes GA. 2018. Synthesis of cholesterol-based neoglycoconjugates and their use in the preparation of liposomes for active liver targeting. Carbohydr Res. 465:52–57. doi: 10.1016/j.carres.2018.06.008.
   PubMed Web of Science ®Google Scholar
• Gheybi F, Alavizadeh SH, Rezayat SM, Hatamipour M, Akhtari J, Faridi Majidi R, Badiee A, Jaafari MR. 2021. PH-sensitive pegylated liposomal silybin: synthesis, in vitro and in vivo anti-tumor evaluation. J Pharm Sci. 110(12):3919–3928. doi: 10.1016/j.xphs.2021.08.015.
   PubMed Web of Science ®Google Scholar
• Guimarães D, Cavaco-Paulo A, Nogueira E. 2021. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 601:120571. doi: 10.1016/j.ijpharm.2021.120571.
   PubMed Web of Science ®Google Scholar
• Haddad F, Mohammed N, Gopalan RC, Ayoub YA, Nasim MT, Assi KH. 2023. Development and optimisation of inhalable egcg nano-liposomes as a potential treatment for pulmonary arterial hypertension by implementation of the design of experiments approach. Pharmaceutics. 15(2):539. doi: 10.3390/pharmaceutics15020539.
   PubMed Web of Science ®Google Scholar
• Hong H, Lu X, Wu C, Chen J, Chen C, Zhang J, Huang C, Cui Z. 2022. A review for the pharmacological effects of paeoniflorin in the nervous system. Front Pharmacol. 13:898955. doi: 10.3389/fphar.2022.898955.
   PubMed Web of Science ®Google Scholar
• Huang S, Ren D, Wu X, Li M, Yu X, Nie X, Wang Y, Wang Y. 2020. Glycyrrhetinic acid and tat peptide modified dual-functional liposomes for treatment of hepatocellular cancer. Curr Top Med Chem. 20(27):2493–2505. doi: 10.2174/1568026620666200722110244.
   PubMed Web of Science ®Google Scholar
• Lei C, Chen Z, Fan L, Xue Z, Chen J, Wang X, Huang Z, Men Y, Yu M, Liu Y, et al. 2022. Integrating metabolomics and network analysis for exploring the mechanism underlying the antidepressant activity of paeoniflorin in rats with cums-induced depression. Front Pharmacol. 13:904190. doi: 10.3389/fphar.2022.904190.
   PubMed Web of Science ®Google Scholar
• Li L, Chen A, Liu B, Pan H, Yu Y, Liu Y. 2022a. Preparation and pharmacokinetics of glycyrrhetinic acid and cell transmembrane peptides modified with liposomes for liver targeted-delivery. Biomed. Mater. 17(4):045006. doi: 10.1088/1748-605X/ac6b73.
   Web of Science ®Google Scholar
• Li R, Zhang J, Liu Q, Tang Q, Jia Q, Xiong Y, He J, Li Y. 2023. CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis. Acta Biomater. 168:484–496. doi: 10.1016/j.actbio.2023.06.032.
   PubMed Web of Science ®Google Scholar
• Li X, Diao W, Xue H, Wu F, Wang W, Jiang B, Bai J, Lian B, Feng W, Sun T, et al. 2020. Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma. Cancer Lett. 489:163–173. doi: 10.1016/j.canlet.2020.06.017.
   PubMed Web of Science ®Google Scholar
• Li Y, Wu J, Lu Q, Liu X, Wen J, Qi X, Liu J, Lian B, Zhang B, Sun H, et al. 2022b. GA&HA-modified liposomes for co-delivery of aprepitant and curcumin to inhibit drug-resistance and metastasis of hepatocellular carcinoma. Int J Nanomedicine. 17:2559–2575. doi: 10.2147/IJN.S366180.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang R, Xu Z, Wang Z. 2022c. Advances in nanoliposomes for the diagnosis and treatment of liver cancer. Int J Nanomedicine. 17:909–925. doi: 10.2147/IJN.S349426.
   PubMed Web of Science ®Google Scholar
• Li Y-L, Zhu X-M, Liang H, Orvig C, Chen Z-F. 2021. Recent advances in asialoglycoprotein receptor and glycyrrhetinic acid receptor-mediated and/or ph-responsive hepatocellular carcinoma-targeted drug delivery. Curr Med Chem. 28(8):1508–1534. doi: 10.2174/0929867327666200505085756.
   PubMed Web of Science ®Google Scholar
• Liu A, Chai X, Zhu S, Chin P-T, He M, Xu Y-J, Liu Y. 2023. Effects of n-succinyl-chitosan coating on properties of astaxanthin-loaded peg-liposomes: environmental stability, antioxidant/antibacterial activities, and in vitro release. Int J Biol Macromol. 244:125311. doi: 10.1016/j.ijbiomac.2023.125311.
   PubMed Web of Science ®Google Scholar
• Liu L, Xing R, Xue J, Fan J, Zou J, Song X, Jia R, Zou Y, Li L, Zhou X, et al. 2023. Low molecular weight fucoidan modified nanoliposomes for the targeted delivery of the anti-inflammation natural product berberine. Int J Pharm. 642:123102. doi: 10.1016/j.ijpharm.2023.123102.
   PubMedGoogle Scholar
• Liu P, Shen J, Cao J, Jiang W. 2024. P-coumaric acid-loaded nanoliposomes: optimization, characterization, antimicrobial properties and preservation effects on fresh pod pepper fruit. Food Chem. 435:137672. doi: 10.1016/j.foodchem.2023.137672.
   PubMed Web of Science ®Google Scholar
• Liu Y, He C-Y, Yang X-M, Chen W-C, Zhang M-J, Zhong X-D, Chen W-G, Zhong B-L, He S-Q, Sun H-T. 2023. Paeoniflorin coordinates macrophage polarization and mitigates liver inflammation and fibrogenesis by targeting the nf-κb/hif-1α pathway in CCL4-induced liver fibrosis. Am J Chin Med. 51(5):1249–1267. doi: 10.1142/S0192415X2350057X.
   PubMedGoogle Scholar
• Ma L, Liu X, Zhang M, Zhou L, Jiang L, Gao L, Wang X, Huang Y, Zeng H, Wu Y. 2023. Paeoniflorin alleviates ischemia/reperfusion induced acute kidney injury by inhibiting slc7a11-mediated ferroptosis. Int Immunopharmacol. 116:109754. doi: 10.1016/j.intimp.2023.109754.
   PubMed Web of Science ®Google Scholar
• Ma Z, Chu L, Liu H, Wang W, Li J, Yao W, Yi J, Gao Y. 2017. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Sci Rep. 7(1):44819. doi: 10.1038/srep44819.
   PubMedGoogle Scholar
• Ming J, Xu Q, Gao L, Deng Y, Yin J, Zhou Q, Tong Q, Zhang Y. 2021. Kinsenoside alleviates 17α-ethinylestradiol-induced cholestatic liver injury in rats by inhibiting inflammatory responses and regulating fxr-mediated bile acid homeostasis. Pharmaceuticals. 14(5):452. doi: 10.3390/ph14050452.
   Web of Science ®Google Scholar
• Nel J, Elkhoury K, Velot É, Bianchi A, Acherar S, Francius G, Tamayol A, Grandemange S, Arab-Tehrany E. 2023. Functionalized liposomes for targeted breast cancer drug delivery. Bioact Mater. 24:401–437. doi: 10.1016/j.bioactmat.2022.12.027.
   PubMed Web of Science ®Google Scholar
• Qi C, Wang D, Gong X, Zhou Q, Yue X, Li C, Li Z, Tian G, Zhang B, Wang Q, et al. 2021. Co-delivery of curcumin and capsaicin by dual-targeting liposomes for inhibition of ahsc-induced drug resistance and metastasis. ACS Appl Mater Interfaces. 13(14):16019–16035. doi: 10.1021/acsami.0c23137.
   PubMed Web of Science ®Google Scholar
• Qu B, Wang X-L, Zheng D-C, Mai C-T, Liu Z-Q, Zhou H, Xie Y. 2022. Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system. Acta Pharmacol Sin. 43(8):2094–2108. doi: 10.1038/s41401-021-00801-6.
   PubMed Web of Science ®Google Scholar
• Shen C, Shen B, Zhu J, Wang J, Yuan H, Li X. 2021. Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin. Drug Dev Ind Pharm. 47(2):207–214. doi: 10.1080/03639045.2020.1862178.
   PubMed Web of Science ®Google Scholar
• Wang D, Yang F, Shang W, Zhao Z, Shen J, Cai H. 2021. Paeoniflorin-loaded ph-sensitive liposomes alleviate synovial inflammation by altering macrophage polarity via stat signaling. Int Immunopharmacol. 101(Pt A):108310. doi: 10.1016/j.intimp.2021.108310.
   PubMedGoogle Scholar
• Wang J, Zhuo J, Tao Y, Xu S, Chen Z, Yang F, Ke Q, Xie H, Zheng S, Wang H, et al. 2020. Salinomycin-loaded small-molecule nanoprodrugs enhance anticancer activity in hepatocellular carcinoma. Int J Nanomedicine. 15:6839–6854. doi: 10.2147/IJN.S236928.
   PubMed Web of Science ®Google Scholar
• Wang R, Yuan T, Sun J, Yang M, Chen Y, Wang L, Wang Y, Chen W, Peng D. 2022. Paeoniflorin alleviates 17α-ethinylestradiol-induced cholestasis via the farnesoid x receptor-mediated bile acid homeostasis signaling pathway in rats. Front Pharmacol. 13:1064653. doi: 10.3389/fphar.2022.1064653.
   PubMed Web of Science ®Google Scholar
• Wang XZ, Xia L, Zhang XY, Chen Q, Li X, Mou Y, Wang T, Zhang YN. 2022. The multifaceted mechanisms of paeoniflorin in the treatment of tumors: state-of-the-art. Biomed Pharmacother. 149:112800. doi: 10.1016/j.biopha.2022.112800.
   PubMed Web of Science ®Google Scholar
• Wei S, Ma X, Niu M, Wang R, Yang T, Wang D, Wen J, Li H, Zhao Y. 2020. Mechanism of paeoniflorin in the treatment of bile duct ligation-induced cholestatic liver injury using integrated metabolomics and network pharmacology. Front Pharmacol. 11:586806. doi: 10.3389/fphar.2020.586806.
   PubMed Web of Science ®Google Scholar
• Wu C, Li B, Zhang Y, Chen T, Chen C, Jiang W, Wang Q, Chen T. 2020. Intranasal delivery of paeoniflorin nanocrystals for brain targeting. Asian J Pharm Sci. 15(3):326–335. doi: 10.1016/j.ajps.2019.11.002.
   PubMed Web of Science ®Google Scholar
• Wu Z, Wang T, Song Y, Lu Y, Chen T, Chen P, Hui A, Chen Y, Wang H, Zhang W, et al. 2019. Optimization on conditions of podophyllotoxin-loaded liposomes using response surface methodology and its activity on pc3 cells. J Liposome Res. 29(2):133–141. doi: 10.1080/08982104.2018.1502303.
   PubMed Web of Science ®Google Scholar
• Xue H, Qin L, Zhang L, Li X, Wu F, Wang W, Wang C, Diao W, Jiang B, Lian B, et al. 2021. Preparation of docetaxel‑loaded, glycyrrhetinic acid‑modified nanoparticles and their liver‑targeting and antitumor activity. Exp Ther Med. 22(4):1144. doi: 10.3892/etm.2021.10578.
   PubMed Web of Science ®Google Scholar
• Yang J, Xiang D, Xiang D, He W, Liu Y, Lan L, Li G, Jiang C, Ren X, Liu D, et al. 2019. Baicalin protects against 17α-ethinylestradiol-induced cholestasis via the sirtuin 1/hepatic nuclear receptor-1α/farnesoid x receptor pathway. Front Pharmacol. 10:1685. doi: 10.3389/fphar.2019.01685.
   PubMed Web of Science ®Google Scholar
• Yang W, Zhang Y, Wang J, Li H, Yang H. 2022. Glycyrrhetinic acid-cyclodextrin grafted pullulan nanoparticles loaded doxorubicin as a liver targeted delivery carrier. Int J Biol Macromol. 216:789–798. doi: 10.1016/j.ijbiomac.2022.07.182.
   PubMed Web of Science ®Google Scholar
• Yuan T, Lv S, Zhang W, Tang Y, Chang H, Hu Z, Fang L, Du J, Wu S, Yang X, et al. 2022. PF-plc micelles ameliorate cholestatic liver injury via regulating tlr4/myd88/nf-κb and pxr/car/ugt1a1 signaling pathways in ee-induced rats. Int J Pharm. 615:121480. doi: 10.1016/j.ijpharm.2022.121480.
   PubMedGoogle Scholar
• Zhai L, Pei H, Shen H, Yang Y, Han C, Guan Q. 2023. Paeoniflorin suppresses neuronal ferroptosis to improve the cognitive behaviors in alzheimer’s disease mice. Phytother Res. 37(10):4791–4800. doi: 10.1002/ptr.7946.
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang Y, Li Z, Li N, Feng N. 2017. Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: optimization, characterization, and evaluation in vitro and in vivo. Int J Nanomedicine. 12:3521–3532. doi: 10.2147/IJN.S135749.
   PubMed Web of Science ®Google Scholar
• Zhao X, Yang Y, Su X, Xie Y, Liang Y, Zhou T, Wu Y, Di L. 2023. Transferrin-modified triptolide liposome targeting enhances anti-hepatocellular carcinoma effects. Biomedicines. 11(10):2869. doi: 10.3390/biomedicines11102869.
   PubMed Web of Science ®Google Scholar
• Zhou H-Q, Liu W, Wang J, Huang Y-Q, Li P-Y, Zhu Y, Wang J-B, Ma X, Li R-S, Wei S-Z, et al. 2017. Paeoniflorin attenuates anit-induced cholestasis by inhibiting apoptosis in vivo via mitochondria-dependent pathway. Biomed Pharmacother. 89:696–704. doi: 10.1016/j.biopha.2017.02.084.
   PubMed Web of Science ®Google Scholar
• Zhou T, Tang X, Zhang W, Feng J, Wu W. 2019. Preparation and in vitro and in vivo evaluations of 10-hydroxycamptothecin liposomes modified with stearyl glycyrrhetinate. Drug Deliv. 26(1):673–679. doi: 10.1080/10717544.2019.1636422.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liu X, Gao Y, Tan R, Wu Z, Zhong Q, Zeng F. 2021. Paeoniflorin affects hepatocellular carcinoma progression by inhibiting wnt/β-catenin pathway through downregulation of 5-ht1d. Curr Pharm Biotechnol. 22(9):1246–1253. doi: 10.2174/1389201021666201009153808.
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang Q, Li H, Zhang H, Zhu Y, Omari-Siaw E, Sun C, Wei Q, Deng W, Yu J, et al. 2018. Galangin-loaded, liver targeting liposomes: optimization and hepatoprotective efficacy. J Drug Delivery Sci Technol. 46:339–347. doi: 10.1016/j.jddst.2018.05.034.
   Web of Science ®Google Scholar
• Zhu Y, Liang J, Gao C, Wang A, Xia J, Hong C, Zhong Z, Zuo Z, Kim J, Ren H, et al. 2021. Multifunctional ginsenoside rg3-based liposomes for glioma targeting therapy. J Control Release. 330:641–657. doi: 10.1016/j.jconrel.2020.12.036.
   PubMed Web of Science ®Google Scholar